Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2026-01-02 @ 12:50 AM
Study NCT ID:
NCT03372057
Status:
COMPLETED
Last Update Posted:
2025-03-07
First Post:
2017-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Sponsor:
SecuraBio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-01
First Submit QC Date:
None
Study First Post Date:
2017-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-19
Results First Submit QC Date:
None
Results First Post Date:
2025-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-05
Last Update Post Date:
2025-03-07
Last Update Post Date Type:
ACTUAL